Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +6.54% | +23.68% | -18.57% |
05-09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
05-09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.57% | 173M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.77% | 22.67B | |
-9.61% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating